Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a0c49e5390c69aa92b87c3a892344c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38df46fac35f3a5bc1944d80226472d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2af9f41ffc2793f94ca903c0cc61d1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255cc5ab27b851334d26e3c51d5f50cc |
publicationDate |
2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2442890-T3 |
titleOfInvention |
Methods and compositions based on micro-RNA for the diagnosis and treatment of diseases related to the colon |
abstract |
A method for diagnosing whether the subject has a colon adenocarcinoma with poor prognosis of survival, which comprises: measuring the level of at least one miR-181b gene product in a test sample of the subject where said subject has colon adenocarcinoma, in that an increase in at least the level of the miR-181b gene product in the test sample, relative to the level of a corresponding miR-181b gene product in a control sample, is indicative that the subject has colon adenocarcinoma with poor survival prognosis. |
priorityDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |